75 related articles for article (PubMed ID: 7953434)
1. Extracellular matrix proteins expression and incidence of tumor infiltrating cells in laryngeal carcinoma.
Jenek R; Kruk-Zagajewska A; Zeromski J
Pol J Pathol; 1994; 45(3):179-86. PubMed ID: 7953434
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix proteins and VLA integrins expression in the microenvironment of human lung carcinoma.
Zeromski J; Lawniczak M; Mizera-Nyczak E; Zocchi MR
Pol J Pathol; 1995; 46(2):63-9. PubMed ID: 7543797
[TBL] [Abstract][Full Text] [Related]
3. Assessment of immunophenotype of potentially cytotoxic tumor infiltrating cells in laryngeal carcinoma.
Zeromski J; Dworacki G; Kruk-Zagajewska A; Szmeja Z; Jezewska E; Kostecka J
Arch Immunol Ther Exp (Warsz); 1993; 41(1):57-62. PubMed ID: 8239909
[TBL] [Abstract][Full Text] [Related]
4. Distribution of the extracellular matrix glycoproteins in ependymomas--an immunohistochemical study with follow-up analysis.
Zámecník J; Chánová M; Tichý M; Kodet R
Neoplasma; 2004; 51(3):214-22. PubMed ID: 15254676
[TBL] [Abstract][Full Text] [Related]
5. [The expression of extracellular matrix in squamous cell carcinoma of the larynx: an immunohistochemical study].
Cao Z; Li X; Ren Z
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Mar; 17(3):167-70. PubMed ID: 12815899
[TBL] [Abstract][Full Text] [Related]
6. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
7. Expression of extracellular matrix-proteins in perisellar connective tissue and dura mater.
Knappe UJ; Fink T; Fisseler-Eckhoff A; Schoenmayr R
Acta Neurochir (Wien); 2010 Feb; 152(2):345-53; discussion 353. PubMed ID: 19730772
[TBL] [Abstract][Full Text] [Related]
8. Expression of tenascin and fibronectin in benign epithelial hyperplastic lesions and squamous carcinoma of the larynx.
Zidar N; Gale N; Kambic V; Fischinger J
Anticancer Res; 2001; 21(1A):451-4. PubMed ID: 11299778
[TBL] [Abstract][Full Text] [Related]
9. A tumor derived motility factor that stimulates cell migration on extracellular matrix.
Klominek J; Robért KH; Sundqvist KG
Anticancer Res; 1998; 18(3A):1601-12. PubMed ID: 9673377
[TBL] [Abstract][Full Text] [Related]
10. Expression of TGF-beta 1 protein and mRNA and the effect on the tissue remodeling in laryngeal carcinomas.
Hagedorn H; Sauer U; Schleicher E; Nerlich A
Anticancer Res; 1999; 19(5B):4265-72. PubMed ID: 10628385
[TBL] [Abstract][Full Text] [Related]
11. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma.
Kosmehl H; Berndt A; Strassburger S; Borsi L; Rousselle P; Mandel U; Hyckel P; Zardi L; Katenkamp D
Br J Cancer; 1999 Nov; 81(6):1071-9. PubMed ID: 10576667
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma.
Linder S; Castaños-Velez E; von Rosen A; Biberfeld P
Hepatogastroenterology; 2001; 48(41):1321-7. PubMed ID: 11677955
[TBL] [Abstract][Full Text] [Related]
13. Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins.
DeRoock IB; Pennington ME; Sroka TC; Lam KS; Bowden GT; Bair EL; Cress AE
Cancer Res; 2001 Apr; 61(8):3308-13. PubMed ID: 11309285
[TBL] [Abstract][Full Text] [Related]
14. Altered extracellular matrices influence cellular processes and nuclear matrix organizations of overlying human bladder urothelial cells.
Gordon JN; Shu WP; Schlussel RN; Droller MJ; Liu BC
Cancer Res; 1993 Oct; 53(20):4971-7. PubMed ID: 8402687
[TBL] [Abstract][Full Text] [Related]
15. Tenascin-C, over expressed in lung cancer down regulates effector functions of tumor infiltrating lymphocytes.
Parekh K; Ramachandran S; Cooper J; Bigner D; Patterson A; Mohanakumar T
Lung Cancer; 2005 Jan; 47(1):17-29. PubMed ID: 15603851
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of the extracellular matrix proteins laminin, fibronectin and type IV collagen in secretory meningiomas.
Caffo M; Caruso G; Galatioto S; Meli F; Cacciola F; Germanò A; Alafaci C; Tomasello F
J Clin Neurosci; 2008 Jul; 15(7):806-11. PubMed ID: 18474427
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness.
Celetti A; Testa D; Staibano S; Merolla F; Guarino V; Castellone MD; Iovine R; Mansueto G; Somma P; De Rosa G; Galli V; Melillo RM; Santoro M
Clin Cancer Res; 2005 Nov; 11(22):8019-27. PubMed ID: 16299231
[TBL] [Abstract][Full Text] [Related]
18. 67-kDa laminin receptor in human laryngeal squamous cell carcinoma.
Zhou L; Xie M; Zhou JQ; Tao L
Laryngoscope; 2006 Jan; 116(1):28-32. PubMed ID: 16481804
[TBL] [Abstract][Full Text] [Related]
19. Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx.
Bárdos H; Juhász A; Répássy G; Adány R
Thromb Haemost; 1998 Nov; 80(5):767-72. PubMed ID: 9843169
[TBL] [Abstract][Full Text] [Related]
20. The relationship between the extracellular matrix and the angiogenesis and metastasis of laryngeal carcinoma.
Han Z; Lin GJ; Chi FL; Wang SY; Huang JM; Liu HJ; Zhang LR
ORL J Otorhinolaryngol Relat Spec; 2008; 70(6):352-8. PubMed ID: 18984970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
